CDC names new acting director

NIH Director Jay Bhattacharya is taking the role after the previous acting director, HHS' Jim O'Neill, exited the department. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

February 18, 2026 Check out STAT+

Sponsored By

There's still time to take advantage of a special STAT+ deal: get 50% off an annual subscription with code FEB2026 at checkout. Thanks for reading!

Nathan Howard/AP STAT+ | NIH Director Bhattacharya to lead CDC after O'Neill's exit Bhattacharya will be the third leader of the public health agency since this summer, but his term is limited by law. By Chelsea Cirruzzo and Anil Oza STAT+ | FDA reverses course, agrees to review Moderna's flu vaccine The decision to review the company's application comes shortly after the earlier rejection sparked major controversy. By Lizzy Lawrence Upcoming meeting of federal vaccine panel may be postponed after HHS missed deadlines Vaccine advisory panel's plans are under legal challenge and its recommendations need approval of the CDC director, a position currently vacant. By Chelsea Cirruzzo Molly Ferguson for STAT STAT+ | The FDA's Moderna pirouette is one more sign of chaos at the agency While the FDA may get past the latest crisis, over a review of a flu vaccine, the volatility at the agency may be here to stay. By Matthew Herper STAT+ | As oncologists ponder how to integrate AI-powered cancer tools, products are hitting the market New digital pathology AI tools, including from Valar Labs, claim to predict chemotherapy response in pancreatic cancer. Doctors see both promise and risk. By Angus Chen STAT+ | At drugmakers' forum, Oz gets a friendly embrace, while Makary faces tough questions CMS chief Mehmet Oz gets a friendly reception at pharmaceutical gathering while FDA head Marty Makary is grilled over recent vaccine decisions. By Lizzy Lawrence and Daniel Payne Yana Paskova/Getty Images Opinion: Same blood test, different results: Why isn't this common thyroid screening reliable? Researchers have known for decades that different brands of lab machines produce different results. The fix is easy — but not enforced. By Samantha Bonsack Opinion: I was a Moderna exec when the Covid vaccine rolled out. That spirit of possibility is no more A former Moderna executive on the sudden, sharp decline in vaccine research in the U.S. By Richard Hughes IV

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser